PIPA173109

Hepatitis C Virus NS5 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA173109-Each-of-1 In Stock ₹ 46,502.50

PIPA173109 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

Hepatitis C Virus NS5

Classification

Polyclonal

Conjugate

Unconjugated

Gene Alias

HCV; HCV NS5; Hepatitis C Virus; HepC; HepC NS5; NICE-3

Immunogen

Recombinant NS5 (genotype 1a).

Quantity

1 mL

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

ELISA, Western Blot

Concentration

4-5 mg/mL

Formulation

PBS with 0.1% sodium azide, pH 7.2

Host Species

Goat

Purification Method

IgG fraction

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA173108

--

Img

Thermo Scientific

PIPA173085

--

Img

Thermo Scientific

PIPA173025

--

Img

Thermo Scientific

PIPA173078

--

Img

Thermo Scientific

PIPA173055

--

Img

Thermo Scientific

PIPA173019

--

Img

Thermo Scientific

PIPA173092

--

Img

Thermo Scientific

PIPA173043

--

Description

  • The PA1-73109 antibody reacts with Hepatitis C virus NS5 antigen
  • PA1-73109 has been successfully used in ELISA, and Western blot applications
  • The PA1-73109 antibody was raised against recombinant NS5 (genotype 1a)
  • Recommended short term storage, less than 6 months, is at 2-8oC
  • For longer term storage, aliquot and freeze
  • HCV is a positive, single-stranded RNA virus in the Flaviviridae family
  • The genome is approximately 10,000 nucleotides and encodes a single polyprotein of about 3,000 amino acids
  • The polyprotein is processed by host cell and viral proteases into three major structural proteins and several non-structural protein necessary for viral replication
  • Several different genotypes of HCV with slightly different genomic sequences have since been identified that correlate with differences in response to treatment with interferon alpha.